2013
DOI: 10.1080/09603123.2013.857390
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of a novel field dilution method for testing samples that exceed the analytic range of point-of-care blood lead analyzers

Abstract: Investigators developed and evaluated a dilution method for the LeadCare II analyzer (LCII) for blood lead levels > 65 μg/dL, the analyzer's maximum reporting value. Venous blood samples from lead-poisoned children were initially analyzed in the field using the dilution method. Split samples were analyzed at the US Centers for Disease Control and Prevention (CDC) laboratory using both the dilution method and inductively coupled plasma-mass spectrometry (

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
6
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 16 publications
1
6
0
Order By: Relevance
“…For reasons of practicality and logistics in this study, we used the LeadCare® II method (LC), but the reference method is inductively coupled plasma mass spectrometry (ICP-MS) (Bonnefoy et al 2002;Palmer et al 2006). Nevertheless, high agreement between the results of ICP-MS and LC has been demonstrated (Sobin et al 2011;Neri et al 2014;Caldwell et al 2019), and LC is one of the methods endorsed by the World Health Organization (2020). Furthermore, in our study blood Pb concentrations were lower than those reported for shooting range users measured with LC (Mathee et al 2017;Naicker et al 2018), which suggests that LC is sufficiently sensitive to detect varying levels of exposure since shooting ranges are particularly polluted sites (Mathee et al 2017).…”
Section: Discussionmentioning
confidence: 99%
“…For reasons of practicality and logistics in this study, we used the LeadCare® II method (LC), but the reference method is inductively coupled plasma mass spectrometry (ICP-MS) (Bonnefoy et al 2002;Palmer et al 2006). Nevertheless, high agreement between the results of ICP-MS and LC has been demonstrated (Sobin et al 2011;Neri et al 2014;Caldwell et al 2019), and LC is one of the methods endorsed by the World Health Organization (2020). Furthermore, in our study blood Pb concentrations were lower than those reported for shooting range users measured with LC (Mathee et al 2017;Naicker et al 2018), which suggests that LC is sufficiently sensitive to detect varying levels of exposure since shooting ranges are particularly polluted sites (Mathee et al 2017).…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, ASV instruments report Pb concentrations above 65 μg/dL as “High.” Samples reading as “High” should be reanalyzed via GFAAS or ICP‐MS, and not diluted and analyzed via ASV as some studies have done (McLelland et al , Reid et al ). Diluting human blood using saline solution consistently overestimated Pb concentrations by two‐fold or greater when analyzed using an ASV because of changes to the blood matrix (Neri et al ). However, one alternative is to use blood samples with very low Pb concentrations (e.g., <2 μg/dL verified by GFAAS–ICP‐MS) as the diluting agent because the blood matrix and the LCA reagent‐mixture is not changed (Neri et al ).…”
Section: Discussionmentioning
confidence: 99%
“…Diluting human blood using saline solution consistently overestimated Pb concentrations by two‐fold or greater when analyzed using an ASV because of changes to the blood matrix (Neri et al ). However, one alternative is to use blood samples with very low Pb concentrations (e.g., <2 μg/dL verified by GFAAS–ICP‐MS) as the diluting agent because the blood matrix and the LCA reagent‐mixture is not changed (Neri et al ). If blood is used to dilute “High” samples, the blood should be from the same species.…”
Section: Discussionmentioning
confidence: 99%
“…VBLL was measured using the LeadCare II (Magellan) point-of-care analyser according to manufacturer protocols. For samples with lead levels >65 µg/dl, the upper quantification limit of the device, a blood dilution method utilising donor blood with lead concentration <3.0 µg/dl [41] was developed and implemented on 20 July 2010. Exclusion of courses with VBLL tests conducted before the dilution protocol was finalised did not substantially alter the results of regression modelling; thus, blood samples obtained at all points in the study period were retained.…”
Section: Methodsmentioning
confidence: 99%